Stringent Regulatory Process for Approvals Creates Hindrance for Global Peripheral Nerve Repair Market

Published Date : Nov 27, 2017

ALBANY, New York, Nov 27, 2017: The rising geriatric population, increasing prevalence of neurological and epidemic disorders, and recent innovation of advanced nerve repair & regeneration products have together supported the global peripheral; nerve repair market in exhibiting promising growth. has added a report, titled “Global Peripheral Nerve Repair Market Analysis By Technique (Direct Repair, Nerve Grafting, Nerve Conduits, Others), By Region, By Country: Opportunities and Forecast (2017-2022) - By Region (North America, Europe, Asia Pacific, RoW); By Country (US, Canada, Germany, France, U.K., China, Australia, South Africa, Brazil),” which studies the various factors enabling growth in the market. It is intended to offer a more holistic overview to the stakeholders, and help market players gauge the investment feasibility in the global peripheral nerve repair market.

Despite several promising factors, stringent process of product approvals is hindering the market’s trajectory to an extent. Nonetheless, the increasing incidence of neurological disorders and peripheral nerve injuries and recent improvements in the healthcare facilities, especially in emerging nations across Asia Pacific will enable the market sustain its pace in the forthcoming years.

To provide a holistic overview of the global peripheral nerve repair market, the report segments it based on various parameters. For instance, in terms of surgery the market can be categorized into nerve grafting, direct neuropathy, stem cell therapy, and neuromodulation surgery. Of these, the neuromodulation surgery segment witnessed high demand in 2016 among patients suffering from neural disorder. Based on product, the market can be bifurcated into neuromodulation surgery and biomaterials devices. The former as per the report exhibited high growth in 2016 due to the plethora of products encompassed within the category.

For Sample Copy, click here:

Regionally, the global peripheral nerve repair market is segmented into North America, Asia Pacific, Europe, and Rest of the World. Among these regions, North America has emerged as a lucrative market for peripheral nerve repair. The presence of several leading diagnostic manufacturers and the rising number of patients suffering from neurological disorders and Alzheimer’s diseases have enabled the market report strong growth in North America. Besides this, the North America market is expected to expand on the back of the regions sophisticated healthcare infrastructure.

However, during the course of the report’s forecast period, the market in Asia Pacific is expected to grow at a higher rate considering the rising incidence of chronic ailments and favorable government initiatives. On account of government support, the healthcare sector in Asia Pacific is slated to expand in the coming years. These factors together have created an environment conducive to growth of the global peripheral nerve repair market. In addition, Latin America offers ample scope to the market. The peripheral nerve repair market in Mexico is forecast to register impressive growth on account of the recent development in the healthcare facilities and the increasing number of patients who require blood and whole blood components.

Besides discussing in detail various aspects within the market influencing strategies of the leading market players, the report also profiles them in detail. Information such as their product portfolio, development status, and recent strategies are factored in to gauge influence they exert on the global peripheral nerve repair market. This reports is intended to gauge the extent of competition in the market. Hence for the purpose of the study, the report includes profiles of companies such as Axogen Inc., Collgan Matrix, Medtronic, Integra Life Sciences Holding Corp, Boston Scientific Corporation, Baxter International, Polyganics, and Stryker Corp.

To order report Call Toll Free: 866-997-4948 or send an email on